Adam M. Hirst
Low temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the future
Hirst, Adam M.; Frame, Fiona M.; Arya, Manit; Maitland, Norman J.; O’Connell, Deborah
Authors
Fiona M. Frame
Manit Arya
Norman J. Maitland
Deborah O’Connell
Contributors
Fiona Frame
Researcher
Abstract
The field of plasma medicine has seen substantial advances over the last decade, with applications developed for bacterial sterilisation, wound healing and cancer treatment. Low temperature plasmas (LTPs) are particularly suited for medical purposes since they are operated in the laboratory at atmospheric pressure and room temperature, providing a rich source of reactive oxygen and nitrogen species (RONS). A great deal of research has been conducted into the role of reactive species in both the growth and treatment of cancer, where long-established radio- and chemo-therapies exploit their ability to induce potent cytopathic effects. In addition to producing a plethora of RONS, LTPs can also create strong electroporative fields. From an application perspective, it has been shown that LTPs can be applied precisely to a small target area. On this basis, LTPs have been proposed as a promising future strategy to accurately and effectively control and eradicate tumours. This review aims to evaluate the current state of the literature in the field of plasma oncology and highlight the potential for the use of LTPs in combination therapy. We also present novel data on the effect of LTPs on cancer stem cells, and speculatively outline how LTPs could circumvent treatment resistance encountered with existing therapeutics.
Citation
Hirst, A. M., Frame, F. M., Arya, M., Maitland, N. J., & O’Connell, D. (2016). Low temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the future. Tumor Biology, 37(6), 7021-7031. https://doi.org/10.1007/s13277-016-4911-7
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 22, 2016 |
Online Publication Date | Feb 18, 2016 |
Publication Date | 2016-06 |
Deposit Date | Jun 20, 2019 |
Publicly Available Date | Jun 21, 2019 |
Journal | Tumor Biology |
Print ISSN | 1010-4283 |
Publisher | SAGE Publications |
Peer Reviewed | Peer Reviewed |
Volume | 37 |
Issue | 6 |
Pages | 7021-7031 |
DOI | https://doi.org/10.1007/s13277-016-4911-7 |
Keywords | General Medicine |
Public URL | https://hull-repository.worktribe.com/output/2020390 |
Publisher URL | https://link.springer.com/article/10.1007%2Fs13277-016-4911-7 |
Contract Date | Jun 21, 2019 |
Files
Article
(2.4 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0
Copyright Statement
© The Author(s) 2016
Open Access
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
You might also like
Effects on prostate cancer cells of targeting RNA polymerase III
(2019)
Journal Article
Phenotype-independent DNA methylation changes in prostate cancer
(2018)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search